| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs6968554 | caffeine | A/G | 7274 | 0.38 | 0.064 (0.009) | 8.68·10-14 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs6968554 |
| Chromosomal location | Chr7: 17,253,631 (7p21.1) |
| Gene (distance) | AHR (-51,169) |
| Predicted causal gene | AHR |
| Gene/protein classification | metabolic enzyme |
| Metabolite (Pathway) | caffeine (Xanthine metabolism; Xenobiotics) |
| Biochemical locus-metabolite relationship | AHR encodes the aromatic hydrocarbon receptor, a transcription factor which activates CYP1A1 and CYP1A2 [10605936]. These enzymes metabolize caffeine [8095225] |
| eQTL associations | - |
| Medical information | |
|---|---|
| Complex trait associations | Caffeine consumption [21490707]; Coffee consumption [21357676] |
| Known metabolite associations | caffeine/quinate [21886157] (r2=0.669 with rs12670403) |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | CHEMBL3201 |
| Drug information | Substrates: Flutamide, Dantrolene, PAHs, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (other PHAHs), ?-naphthoflavone, indigoids, tryptophan metabolites, omeprazole, lansoprazole; Inhibitors: CH-223191, ?-naphthoflavon, omerprazole sulfide |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








